News
Regeneron, Sanofi to Co-Develop Four New Long-Acting Antibodies
Regeneron to receive USD 1 billion upfront payment from Sanofi, with potential for up to an additional USD 7 billion in future milestone payments.
imphoenix82
- October 1, 2026
- 0 Comments
- 164 Views
-
